AmerisourceBergen gets Express Scripts job; Catalent likes single-use reactors;

> AmerisourceBergen ($ABC) has been tapped to be the drug distributor for pharmaceutical benefit manager Express Scripts ($ESRX) beating out Cardinal Health ($CAH). Story

> Catalent has replaced its stainless steel bioreactors at its biologics facility in Middleton, WI, with disposable technology. Story

> Alnylam Pharmaceuticals received a $3.2 million milestone payment from GlaxoSmithKline ($GSK) for new manufacturing technology for a GSK vaccine. Item

> Granules India reports higher sales as demand from China drove its API business. Story

> A congressional report says some U.S. pharmacies are selling all of their inventories into the gray market at huge markups. Story

And Finally... Canada is looking at establishing a bidding process to buy generics nationally in hopes of getting them cheaper. Story

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.